Skip to main content
Mauna Kea Technologies logo

Mauna Kea Technologies — Investor Relations & Filings

Ticker · MKEA ISIN · FR0010609263 LEI · 5493007KMDG4MFIGJJ63 PA Manufacturing
Open in API
Filings indexed 770 across all filing types
Latest filing 2025-06-02 Regulatory Filings
Country FR France
Listing PA MKEA

About Mauna Kea Technologies

https://www.maunakeatech.com/en/

Mauna Kea Technologies is a medical device company that develops and markets the Cellvizio® platform, a real-time in vivo cellular imaging system. The platform utilizes Confocal Laser Endomicroscopy (CLE) technology, enabling physicians to visualize tissue at the cellular level during medical procedures. This "optical biopsy" is performed using flexible, miniature fiber-optic probes (Confocal Miniprobes™) that are compatible with standard endoscopes. The core function of Cellvizio® is to provide immediate microscopic visualization, which aids in accelerating diagnosis, informing treatment strategies, and improving the precision of therapeutic interventions. Key applications include gastroenterology (for conditions such as Barrett's esophagus and pancreatic cysts), interventional pulmonology (lung cancer diagnostics), urologic oncology, and neurosurgery. The technology supports enhanced surgical procedures, including real-time margin assessment, and is being integrated with robotic surgery and AI-assisted imaging systems.

Recent filings

Filing Released Lang Actions
Inside Information / Other news releases
Regulatory Filings Classification · 95% confidence The document is titled as an announcement: "Mauna Kea Technologies Announces Major AI Breakthrough...". It details scientific results published in a peer-reviewed journal and quotes company executives and lead researchers. It is dated June 2, 2025, and is clearly a press release format, not a comprehensive regulatory filing like a 10-K or IR. It is not a transcript (CT), a formal dividend notice (DIV), or a proxy statement (PSI). Since it is an announcement of significant business/scientific news, it fits best as an Earnings Release (ER) if it were tied to quarterly results, but here it is a specific scientific/product development announcement. Given the options, this type of press release announcing a major development, often released outside of standard quarterly reporting cycles, is frequently categorized as a general Regulatory Filing (RNS) if it doesn't fit the specific financial report types. However, because it is a formal announcement of a major business/product development, and often these press releases are filed via the RNS system or similar mechanisms, RNS is the most appropriate fallback. It is not an ER because it is not focused on financial performance highlights for a period. It is not an RPA because it is the content itself, not just an announcement that content is available. Therefore, RNS (Regulatory Filings/General Announcement) is the best fit among the provided codes for a non-standard, material press release.
2025-06-02 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 95% confidence The document is a press release from Mauna Kea Technologies dated June 2, 2025, announcing major results regarding their Cellvizio technology combined with AI for pancreatic cyst risk stratification. It details scientific study outcomes, compares performance metrics (AUC, sensitivity, specificity) against human experts, and includes quotes from management and researchers. This format—a formal announcement of significant operational/scientific news intended for investors and the public—is characteristic of an Earnings Release (ER) or a general press release. Since it is not a full annual report (10-K), a quarterly report (IR), a transcript (CT), or a specific regulatory filing like a Director's Dealing (DIRS) or Proxy Statement (PSI), the most appropriate classification for a major, time-sensitive announcement of results is Earnings Release (ER), as these often contain key performance highlights and scientific breakthroughs that drive investor interest, even if not strictly tied to quarterly financials. Given the content focuses heavily on scientific validation and market potential rather than just financial figures, it could also be considered a Regulatory Filing (RNS) if ER is too narrow, but ER is often used for major positive announcements. However, since it is a general press release announcing a scientific/business milestone, and not explicitly tied to a quarterly financial period summary, it fits best as a general announcement or a specific type of press release. Since 'ER' is defined as 'Initial announcement of quarterly/periodical financial results (key highlights only)', and this is a scientific/business highlight announcement, 'RNS' (Regulatory Filings / general regulatory announcements and fallback category) is a safer fit for a non-standard financial announcement, although 'ER' is plausible if the company treats major announcements this way. Given the context of financial reporting databases, major non-financial announcements often default to RNS unless they are clearly an ER or IR. I will classify it as RNS as it is a general press release announcing a scientific/business milestone, not strictly an earnings report.
2025-06-02 French
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 92% confidence The document is a press release from Mauna Kea Technologies dated May 21, 2025, providing an update on its ongoing 'procédure de sauvegarde' (safeguard procedure), strategic discussions (licensing agreement), and operational progress (CellTolerance adoption). It discusses financial restructuring efforts and business updates but does not contain the full, detailed financial statements characteristic of an Annual Report (10-K) or an Interim Report (IR). It is an announcement intended to keep stakeholders informed about significant corporate events, including legal/financial status updates and business momentum. This type of general corporate update, especially one detailing legal proceedings ('sauvegarde') and strategic negotiations, fits best under the general 'Regulatory Filings' (RNS) category as a significant, non-standard announcement, or potentially as a Legal Proceedings Report (LTR) due to the explicit mention of the safeguard procedure. However, since it covers multiple facets (legal status, strategy, operations) and is structured as a general update press release, RNS is the most appropriate general regulatory filing category when specific categories like ER or IR do not apply. Given the focus on the ongoing legal/restructuring process, it is a significant regulatory disclosure.
2025-05-21 French
Inside Information / Other news releases
Legal Proceedings Report Classification · 99% confidence The document is titled as an "Update" providing information on safeguard proceedings, strategic discussions (licensing agreement), and operational progress (CellTolerance adoption). It is structured like a formal press release, dated May 21, 2025, and includes contact information for Investor Relations and a standard disclaimer referencing forward-looking statements and the Annual Report filed with the AMF. This content—an update on ongoing legal/financial restructuring (safeguard proceedings) and business developments—does not fit the specific definitions for 10-K (full annual report), ER (initial earnings release), IR (comprehensive interim report), or CT (call transcript). It is an announcement providing material, non-financial/non-earnings-specific operational and legal status updates. Since it is a general update on legal/financial status and strategic negotiations, it is best classified as a general Regulatory Filing (RNS) or potentially a Legal Proceedings Report (LTR) due to the mention of safeguard proceedings. However, RNS is the most appropriate general category for non-standard, material corporate announcements that don't fit the other specific categories like DIV, DIRS, or ER. Given the context of providing updates on restructuring and strategic talks, RNS serves as the best fit among the available options for a general corporate status update press release.
2025-05-21 English
Modalités de mise à disposition des documents préparatoires à l'AG
Proxy Solicitation & Information Statement Classification · 98% confidence The document is a press release dated May 20, 2025, announcing the availability of preparatory documents for the Annual General Meeting (Assemblée Générale Mixte) scheduled for June 5, 2025. It details the agenda, voting procedures (VOTACCESS, postal, in person), and where to find the required materials (BALO publication, company website). This content directly relates to the materials and procedures surrounding a shareholder meeting, specifically the notice and related documents required before the meeting. This aligns perfectly with the definition of Proxy Solicitation & Information Statement (PSI), which covers materials sent to shareholders to provide information and request votes for meetings. While it mentions the AGM, the core function of this specific announcement is to inform shareholders about the documents and voting mechanics, making PSI the most precise fit over AGM-R (which is usually the presentation/minutes of the meeting itself).
2025-05-20 French
Terms of availability of the preparatory documents for the GM
AGM Information Classification · 98% confidence The document is titled "Mauna Kea Technologies announces the availability of preparatory documents for the Combined General Meeting of June 5, 2025 and the instructions for participation". It explicitly discusses the notice of the meeting, the agenda, proposed resolutions, and instructions for participating and voting at the Combined General Meeting (AGM). This content directly relates to the materials prepared for and distributed before an Annual General Meeting. Therefore, the most appropriate classification is AGM Information (AGM-R). Although it announces the availability of documents, the core subject matter is the AGM itself, making AGM-R more specific than RPA or RNS.
2025-05-20 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.